Galenamox | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Galenamox
US Exclusivities

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

With Virupaksha, you get a quality product with on-time delivery.

Contact Supplier

pharmacompass-1-m-2025-11-24

PharmaCompass Sponsored Ads

Contact Supplier

ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

Contact Supplier

pharmacompass-2-m-2025-11-03

Galenamox

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

108 API Suppliers, 40 USDMF, 31 CEP/COS, 5 JDMF, 2 EU WC, 41 KDMF, 20 NDC API, 4 VMF, 26 Listed Suppliers, $ API Reference Price

108 API Suppliers
40 USDMF
31 CEP/COS
5 JDMF
2 EU WC
41 KDMF
20 NDC API
4 VMF
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

109 Drugs in Development

109 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1753 FDF Dossiers, 208 FDA Orange Book, 684 Europe, 114 Canada, 130 Australia, 223 South Africa, 394 Listed Dossiers

1753 FDF Dossiers
208 FDA Orange Book
684 Europe
114 Canada
130 Australia
223 South Africa
394 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML, FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML, TABLET;ORAL - 875MG;EQ 125MG BASE, FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML, CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - 400MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 775MG, CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 250MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG;EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 125MG/5ML;EQ 31.25MG BASE/5ML
FOR SUSPENSION;ORAL - 250MG/5ML;EQ 62.5MG BASE/5ML
TABLET;ORAL - 875MG;EQ 125MG BASE
FOR SUSPENSION;ORAL - 200MG/5ML;EQ 28.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 400MG/5ML;EQ 57MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 600MG/5ML;EQ 42.9MG BASE/5ML
CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL - 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 200MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
FOR SUSPENSION;ORAL - 400MG/5ML
TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 62.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 775MG
CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL - 500MG,N/A,N/A;N/A,500MG,N/A;N/A,N/A,20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 1 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 2 CD Formulation, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 1 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 22 Thickeners and Stabilizers, 22 Fillers, Diluents & Binders, 19 Controlled & Modified Release, 14 Disintegrants & Superdisintegrants, 11 Lubricants & Glidants, 10 Topical, 9 Granulation, 9 Direct Compression, 7 Rheology Modifiers, 7 Co-Processed Excipients, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Taste Masking, 5 Solubilizers, 4 Coloring Agents, 4 Emulsifying Agents, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 1 Parenteral

39 Coating Systems & Additives
22 Thickeners and Stabilizers
22 Fillers, Diluents & Binders
19 Controlled & Modified Release
14 Disintegrants & Superdisintegrants
11 Lubricants & Glidants
10 Topical
9 Granulation
9 Direct Compression
7 Rheology Modifiers
7 Co-Processed Excipients
6 Film Formers & Plasticizers
5 Empty Capsules
5 API Stability Enhancers
5 Taste Masking
5 Solubilizers
4 Coloring Agents
4 Emulsifying Agents
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
1 Parenteral

DIGITAL CONTENT

78 News #PharmaBuzz

78 News #PharmaBuzz

GLOBAL SALES INFORMATION

25 US Medicaid Prescriptions, 363 Regulatory FDF Prices, 11 Annual Reports

25 US Medicaid Prescriptions
363 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

105 APIs, 44 FDF Dossiers

105 APIs
44 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 6 US Exclusivities, 2 Health Canada Patents

14 US Patents
6 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 30 Others

3 EDQM
2 USP
30 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ API Ref.Price (USD/KG) : 31 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 4PHATHOM

02 2TALICIA HOLDINGS

filter Product Reset all filters

6 All

01 2AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

02 2AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

03 2AMOXICILLIN; VONOPRAZAN FUMARATE

filter Exclusivity Expiration Date Reset all filters

6 All

01 12022-11-01

02 22027-05-03

03 12027-11-01

04 22032-05-03

filter Exclusivity Code Reset all filters

6 All

01 3GAIN

02 2NCE

03 1NP

Product Main Page

PHATHOM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

AMOXICILLIN; VONOPRAZAN FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2027-05-03

Application Number

215153

Product Number

1

Exclusivity Details

01

PHATHOM

AMOXICILLIN; VONOPRAZAN FUMARATE

AES

Not Confirmed

PHATHOM

U.S.A

AES

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; VONOPRAZAN FUMARATE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-05-03

Application Number : 215153

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

PHATHOM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NCE

Exclusivity Expiration Date

2027-05-03

Application Number

215152

Product Number

1

Exclusivity Details

02

PHATHOM

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

AES

Not Confirmed

PHATHOM

U.S.A

AES

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-05-03

Application Number : 215152

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

TALICIA HOLDINGS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2027-11-01

Application Number

213004

Product Number

1

Exclusivity Details

03

TALICIA HOLDINGS

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

AES

Not Confirmed

TALICIA HOLDINGS

Country

AES

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2027-11-01

Application Number : 213004

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

TALICIA HOLDINGS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2022-11-01

Application Number

213004

Product Number

1

Exclusivity Details

04

TALICIA HOLDINGS

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

AES

Not Confirmed

TALICIA HOLDINGS

Country

AES

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN

Exclusivity Code : NP

Exclusivity Expiration Date : 2022-11-01

Application Number : 213004

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

PHATHOM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

AMOXICILLIN; VONOPRAZAN FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2032-05-03

Application Number

215153

Product Number

1

Exclusivity Details

05

PHATHOM

AMOXICILLIN; VONOPRAZAN FUMARATE

AES

Not Confirmed

PHATHOM

U.S.A

AES

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; VONOPRAZAN FUMARATE

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2032-05-03

Application Number : 215153

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

PHATHOM

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

GAIN

Exclusivity Expiration Date

2032-05-03

Application Number

215152

Product Number

1

Exclusivity Details

06

PHATHOM

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

AES

Not Confirmed

PHATHOM

U.S.A

AES

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

AMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE

Exclusivity Code : GAIN

Exclusivity Expiration Date : 2032-05-03

Application Number : 215152

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!